AVTX vs TYL · P/E 0.0, $51.5M cap vs P/E 89, rev $1.26B
Avalo Therapeutics Inc (AVTX) versus Tyler Technologies Inc (TYL) — a side-by-side from cached financials, not a winner call.
Avalo Therapeutics Inc (AVTX) is a biotechnology company listed on US.
Tyler Technologies Inc (TYL) is a software - application company listed on US.
Latest reported AVTX revenue for 2025-09-30 was $0. Net income was -$30.6M. AVTX currently screens at market cap $51.5M and trailing P/E 0.0.
Latest reported TYL revenue for 2026-06-30 was $1.26B. Net income was $174.7M. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
AVTX currently screens at market cap $51.5M and trailing P/E 0.0. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
Not investment advice. Open the AVTX and TYL stock pages for the full models.
Not investment advice.